Something to ponder for those who intend to hold EMV long term.
Cochlear (COH) sold 24,000 units last year for revenue of $1.3 billion. Market cap $21 billion
I would argue strongly that EMV's addressable market for EMU and the ambulance/air gen 2 will be much larger than COH's addressable market.
Stroke is a far bigger market than ear implants. No comparison.
When EMV sells 6,500 units a year at AUD$200,000 per unit we are then at the same revenue as COH.
Long term I expect more than 6,500 units a year PLUS all the accessory revenue associated with those units.
Ann: Pilot Production Line Established & $1.25m Grant Received, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
-0.005(0.28%) |
Mkt cap ! $151.7M | |||
| Open | High | Low | Value | Volume |
| $1.80 | $1.85 | $1.77 | $79.50K | 44.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 525 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.83 | 8500 | 2 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| EMV (ASX) Chart |